Alternatives to Imipenem/Cilastatin If You Can't Fill Your Prescription

Imipenem/Cilastatin (Primaxin) is one of the most powerful broad-spectrum antibiotics available, but when it's in shortage or unavailable, your medical team may need to pivot to an alternative. The good news: there are several carbapenem and non-carbapenem alternatives that cover similar bacterial spectrums. The right choice depends entirely on your infection, the specific bacteria involved, your kidney function, and your clinical history. Always consult your prescribing physician or infectious disease specialist before switching.

Important: Don't Switch Antibiotics on Your Own

Before reviewing alternatives, a critical point: antibiotic selection is a medical decision that must be made by a qualified physician or infectious disease specialist. Your specific culture and sensitivity results, the site of infection, and your medical history all factor into which antibiotic is most appropriate. This article is educational — it explains what alternatives exist and why they may or may not be suitable, not which one you should take.

Alternative #1: Meropenem (Merrem) — The Most Common Substitute

Meropenem is the most widely used alternative to Imipenem/Cilastatin. It is also a carbapenem antibiotic with a very similar spectrum of activity. Key differences:

• Meropenem has a lower seizure risk than imipenem, making it preferred for patients with CNS disease or seizure history

• Meropenem can be used for bacterial meningitis — imipenem cannot, because it doesn't adequately penetrate the blood-brain barrier

• Meropenem is slightly more active against gram-negative bacteria including Pseudomonas aeruginosa

• Does not require cilastatin — meropenem is stable in the kidney without a protective companion drug

Meropenem is FDA-approved for intra-abdominal infections, bacterial meningitis, and complicated skin/soft tissue infections. In practice, it is used broadly for serious infections including sepsis, hospital-acquired pneumonia, and febrile neutropenia.

Alternative #2: Ertapenem (Invanz) — Once-Daily Option

Ertapenem is a carbapenem with a key advantage: it can be dosed once daily (1 gram IV or IM every 24 hours), compared to Imipenem/Cilastatin which is given every 6–8 hours. This makes ertapenem a practical option for outpatient IV therapy.

However, ertapenem has a critical limitation: it has NO activity against Pseudomonas aeruginosa or Acinetobacter species. This makes it unsuitable for infections where these resistant pathogens are suspected or confirmed. It is best suited for community-acquired infections with susceptible organisms (Enterobacteriaceae, streptococci, anaerobes).

Alternative #3: Piperacillin-Tazobactam (Zosyn) — Beta-Lactam/BLI Combination

Piperacillin-tazobactam (Pip-Tazo or Zosyn) is a broad-spectrum beta-lactam antibiotic combined with a beta-lactamase inhibitor. While it is not a carbapenem, it provides broad gram-negative, gram-positive, and anaerobic coverage and is often used for:

• Intra-abdominal infections and peritonitis

• Hospital-acquired and healthcare-associated pneumonia

• Complicated UTIs and skin/soft tissue infections

The key limitation: Pip-Tazo is susceptible to more beta-lactamases than carbapenems, meaning it may not work for ESBL-producing bacteria or carbapenem-resistant organisms (CREs) — infections where Imipenem/Cilastatin would typically be used.

Alternative #4: Ceftazidime-Avibactam (Avycaz) — For Drug-Resistant Infections

For infections caused by carbapenem-resistant Enterobacterales (CRE) or drug-resistant Pseudomonas aeruginosa, ceftazidime-avibactam (Avycaz) may be considered. Avibactam is a novel beta-lactamase inhibitor that extends coverage to many carbapenem-resistant organisms. This drug is typically reserved for multidrug-resistant infections under infectious disease specialist guidance.

Alternative #5: Doripenem (Doribax)

Doripenem is another carbapenem with a spectrum of activity similar to meropenem. It is less commonly used in routine practice but may be available when meropenem and imipenem/cilastatin are both in short supply. Like meropenem, it can be used for serious gram-negative infections including Pseudomonas aeruginosa.

Side-by-Side Comparison of Imipenem/Cilastatin Alternatives

• Meropenem: Broad spectrum including Pseudomonas, lower seizure risk, can be used for meningitis. Best overall substitute.

• Ertapenem: Once-daily dosing, great for OPAT, but no Pseudomonas coverage.

• Piperacillin-Tazobactam: Good broad-spectrum coverage but may not work for ESBL or CRE infections.

• Ceftazidime-Avibactam: Reserve drug for carbapenem-resistant organisms; very expensive.

• Doripenem: Broad-spectrum carbapenem similar to meropenem; less commonly available.

What If None of the Alternatives Are Right for My Infection?

For infections involving highly resistant organisms (such as carbapenem-resistant Acinetobacter or Pan-resistant bacteria), there may be very limited options. In these cases, an infectious disease specialist is essential. They can consult with clinical pharmacists, reference labs, and even manufacturer medical affairs teams to identify treatment options.

Don't Give Up on Finding Imipenem/Cilastatin First

Before switching to an alternative, make sure you've exhausted your options to find the medication. medfinder calls pharmacies and infusion centers near you to check stock — which is especially valuable for a hospital-use antibiotic like Imipenem/Cilastatin. For more on locating the drug, see our guide on how to find Imipenem/Cilastatin in stock near you.